April 2024 - Page 9 of 18

WednesdayApr 17, 2024 3:27 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) to Launch Referral Partner Program

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, has announced the launch of its Sekur Referral Program for existing users and business referral partners. The goal of the program is to increase sales and reduce customer acquisition costs as the company embarks on its road to profitability. “We are very excited to launch our Sekur Referral Program for professionals and existing Sekur users. Sekur users are very passionate about their privacy, and we have received many requests for such a program. We believe this will accelerate sales, reduce costs of customer…

WednesdayApr 17, 2024 2:58 pm

QualityStocksNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) Announces Enhanced Features of 2024 Lucid Air Grand Touring Model

Lucid Group (NASDAQ: LCID), a company setting new standards for the luxury electric experience with the Lucid Air, America's most awarded new luxury vehicle, has released details about its 2024 Lucid Air Grand Touring. This year’s model features enhancements designed to help people drive farther and charge faster in a broader range of environments and conditions. Enhanced features include an EPA-estimated range of 516 miles, the longest range of any EV in the U.S. market today; more efficiency and more sustainable performance, thanks to the vehicle’s proprietary motor design, battery cell chemistry and thermal characteristics; and an estimated 15%–30% faster…

WednesdayApr 17, 2024 2:46 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Expansion of Investigative Pipeline

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company today announced the expansion of its pipeline into metabolic and related disorders including weight loss and liver health. FSD Pharma has initiated investigations into certain ingredients and combinations of ingredients that show promise in improving liver health, reducing metabolic disease and reducing visceral fat. The company is leading these efforts to potentially create a new exciting product line in addition to unbuzzd(TM). To view the full press release, visit https://ibn.fm/mpMNa About FSD Pharma Inc. FSD is…

WednesdayApr 17, 2024 9:45 am

DGE 4th KOL & Advanced Practice Providers Forum Attendees to Gather In Philadelphia

Biotech, pharma, and life science companies and professionals are invited to attend the 4th KOL & Advanced Practice Providers Forum, hosted by Dynamic Global Events (“DGE”), in Philadelphia April 29-30th, as an in-person conference with an online streaming option. A global leader in organizing networking events, DGE focuses on delivering the highest-quality data and networking avenues to the Pharmaceutical, Biotechnology, Medical Device, and Healthcare sectors. Over the next decade, the Key Opinion Leader (“KOL”) market is expected to grow at a rate of 12.5%. New technology developments have changed baseline expectations for KOL outreach and relationship management, so your team needs…

WednesdayApr 17, 2024 9:00 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects

Electric vehicles are expected to account for over 50% of automobile sales in 2040, driving a six-fold increase in global nickel demand Fathom Nickel has looked to capitalize on the world’s ambitions for a carbon-neutral future through the exploration and development of two promising nickel deposits located within Canada’s Saskatchewan province The site of historic exploratory and mining activity during the 1960’s, initial exploration work across both the Albert Lake and Gochager Lake projects have found great potential in terms of resource and mineral yields Forecasts suggest that by 2040, electric vehicles (“EVs”) will comprise over 50 percent of annual…

TuesdayApr 16, 2024 3:50 pm

QualityStocksNewsBreaks – Podfest Expo Names IBN as Official Media Partner for Premier Podfest Master Class

Podfest Expo and its parent company, Cutting Edge Events, has selected InvestorBrandNetwork (“IBN”), a pioneer in corporate communications and content distribution, to be the official media partner for its upcoming Podfest Master Class. The virtual master class is scheduled for April 19, 22–24, 2024. This unique event is designed to be premier online summit and foremost platform for world-class education and quality content creation exclusively for the global podcasting community. This year’s event is focused on AI and creator tools, with an agenda featuring unparalleled educational experiences, technological insights, and top-tier content creation and dissemination; the event also includes invaluable networking…

TuesdayApr 16, 2024 3:46 pm

QualityStocksNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain

Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ Events, Vape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, the Vape South America Medellín 2024 has become a prime gateway between the U.S. and South American markets and offers a unique opportunity to establish connections with buyers and distributors from around the globe. “Vape South America Medellín 2024 is a globally renowned platform in…

TuesdayApr 16, 2024 3:39 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, subject recruitment will begin immediately with the first dosing expected within the next month; the company plans to complete the study this summer. The study will be comprised of two study arms and will include up to nine healthy volunteers. The study is designed to…

TuesdayApr 16, 2024 3:09 pm

QualityStocksNewsBreaks – Bebuzee Inc. (BBUZ) Prepares to Launch Game-Changing Super App, Engages IBN for Corporate Communications Expertise

Bebuzee (OTC: BBUZ), a pioneer in the social platform and streaming service industry, today announced that it is moving beyond its beta phase and is now gearing up for the official launch of its Super App. Poised to be the first Super App in America and Europe, Bebuzee is set to revolutionize the digital world by offering a comprehensive and seamless solution that integrates multiple services into a single platform. “The Bebuzee Super App is not just an app; it’s a revolution. We’re about to change the game by offering a comprehensive digital ecosystem that caters to every user’s needs,…

TuesdayApr 16, 2024 1:33 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

Site Search

Company Search

Month: April 2024